Patient-Centric Research: How Optimized Trials Enhance Patient Enrollment, Retention, And More

Clinical research faces significant challenges: developing a new drug can take 7-13 years, with 85% of trials missing their timelines, less than 15% minority representation, and dropout rates as high as 30%. Recent efforts to address these issues include decentralized clinical trials (DCTs), also known as “optimized trials.” These trials are becoming increasingly popular because they focus on patient access, aiming to meet patients where they are to improve enrollment and retention.

Join the Elligo Elite Learning Series for the presentation “Patient-Centric Research: How Optimized Trials Enhance Patient Enrollment, Retention, and More.” This session will explore how optimized trials, blending DCT elements with traditional methods and advanced research technology, address common research challenges. Experts from Elligo Health Research®—including CEO Barry Simms, Dr. Faith Holmes, Chief Medical Officer, Jacylyn Dougherty, Chief Product & Technology Officer, and Leslie Carney, Senior Director of Patient Support Recruitment & Marketing—will discuss the benefits, challenges, and solutions associated with optimized trials. Discover how leveraging these strategies can solve key issues in clinical research and enhance your trials' success.

This presentation originally premiered on https://xtalks.com/